Absolutely. Mid-way through Q4, I’m hoping we get some visibility to how Q4 is expected to fare vs Q3. The confidence that Nasrat had last call may have surpassed the “FDA cannot stop us” cc. Eager to see Kirko deliver and pipeline progression. Expecting those small FDA approvals soon too…